SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-129202
Filing Date
2023-12-26
Accepted
2023-12-26 16:15:24
Documents
1
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2332647-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2332647-6_4seq1.xml 4 8276
  Complete submission text file 0001104659-23-129202.txt   9761
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE, 33RD FLOOR NEW YORK NY 10169
Business Address
Gad Thomas (Reporting) CIK: 0001753224 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 231513488